Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Axitinib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Axitinib 1mg tablets
0801050BJAAAAAA
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Axitinib 3mg tablets
0801050BJAAADAD
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Axitinib 5mg tablets
0801050BJAAABAB
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Axitinib 7mg tablets
0801050BJAAACAC
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Inlyta 1mg tablets
0801050BJBBAAAA
|
Inlyta | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Inlyta 3mg tablets
0801050BJBBADAD
|
Inlyta | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Inlyta 5mg tablets
0801050BJBBABAB
|
Inlyta | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Inlyta 7mg tablets
0801050BJBBACAC
|
Inlyta | Axitinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.